Clinical Trial Update: TB Immunotherapy Trial With Heat-killed M. Vaccae [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a heat-killed Mycobacterium vaccae immunotherapy targeting tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Heat-killed Mycobacterium vaccae immunotherapy (Mycobacterium vaccae immunotherapy)

Snippet

Sponsor: Immunitor LLC | Conditions: Tuberculosis | Phase 3 | Status: COMPLETED